The American Cancer Society said that Karen E. Knudsen “announced her desire to transition” from her role as CEO of the 111-year-old charity in order to pursue “the next phase of her strategy to accelerate progress against cancer.”
A meta-analysis of 25 studies—totaling over 5,000 participants—focused on a question that has been troubling patients, physicians, and regulators: Does treatment with CAR T-cell therapy contribute to the development of secondary cancers?
Tumors are able to form without any DNA mutations, according to a recent proof-of-principle study performed in flies. Epigenetic changes alone—even temporary alterations—induced permanent cancer cell fate.
I was a practicing pediatric hematologist oncologist and researcher for 21 years. As a doctor, it was a tremendous privilege to be invited into the lives of patients and families dealing with blood cancers and be entrusted with their care. As a researcher, it was incredibly rewarding to help bring more effective blood cancer therapies to kids.
A recent article in JAMA Network Open published by myself and my research collaborators—Jill Harrison at Brown University, Sarah Yarborough at Fred Hutch, and Tammy Stokes at Maury Regional Medical Center—examined the potential for a brief communication-based intervention to help older adults with cancer who live in rural settings better manage their pain.
Thomas Schwaab was named Bank of America Endowed Medical Director of ChristianaCare’s Helen F. Graham Cancer Center & Research institute.
Mayo Clinic received a $50 million investment from Stephen M. and Barbara J. Slaggie of Marco Island, FL, and Winona, MN.
Carolyn M. Tucker, Ph.D., received a 2024 President’s Lifetime Achievement Award from the office of U.S. President Joe Biden. Photo credit: Carolyn TuckerCarolyn M. Tucker has received a 2024 President’s Lifetime Achievement Award from the office of President Joe Biden, in recognition of her work to build healthier communities and providing hundreds with power over cancer.
Joshua Mammen was named physician-in-chief at the Nebraska Medicine Fred & Pamela Buffett Cancer Center.
David Voce joined Tampa General Hospital and USF Health as an assistant professor in the USF Health Morsani College of Medicine Department of Neurosurgery & Brain Repair in the Division of Cranial and Neuro-Oncology.
